Found 9 matching trials
A Phase II Safety and Tolerability Study of TCB008 in Patients With COVID-19 PHASE2 A Phase II safety and tolerability study of expanded gamma delta T cell lym...
Show More Location
Royal Victoria Infirmary
Learn More & Join Trial
Allogeneic "Gammadelta T Cells (γδ T Cells)" Cell Immunotherapy in Phase 1 Hepatocellular Carcinoma Clinical Trial EARLY_PHASE1 This study aims to evaluate the safety, tolerability and efficacy of ex-viv...
Show More Location
Beijing 302 Hospital of China
Learn More & Join Trial
Allogeneic γδ T Cells Immunotherapy in r/r Non-Hodgkin's Lymphoma (NHL) or Peripheral T Cell Lymphomas (PTCL) Patients EARLY_PHASE1 This study aims to evaluate the safety, tolerability and efficacy of ex-viv...
Show More Location
Institute of Hematology & Blood Disease Hospital
Learn More & Join Trial
A Clinical Study on the Safety, Tolerance, and Preliminary Efficacy of γδ-T Cell Injection in the Treatment of Advanced Bladder Cancer N/A We plan to enroll 20-29 patients with advanced bladder cancer to undergo T-...
Show More Location
Multiple Locations
Learn More & Join Trial
Ex-vivo Expanded γδ T-lymphocytes (OmnImmune®) in Patients With Acute Myeloid Leukaemia (AML) PHASE1 This study investigates the potential curative properties of gamma delta T-...
Show More Location
UHKT (Ustav hematologie a krevni transfuze)
Learn More & Join Trial
Safety and Efficiency of γδ T Cell Against Hematological Malignancies After Allo-HSCT PHASE1 This study investigates the infusion safety and potential curative properti...
Show More Location
Chinese PLA General Hospital
Learn More & Join Trial
Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide PHASE1 Gamma delta T-cells are part of the innate immune system with the ability t...
Show More Location
University of Kansas Cancer Center
Learn More & Join Trial
ACHIEVE - Efficacy and Effectiveness of Adoptive Cellular tHerapy wIth Ex-Vivo Expanded Allogeneic γδ T-lymphocytes (TCB008) for Patients With Refractory or Relapsed Acute Myeloid Leukaemia (AML) PHASE2 This is an open-label, phase II study designed to evaluate the efficacy and...
Show More Location
Bristol and Weston NHS foundation trust
Learn More & Join Trial
Allogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed /Refractory Neuroblastoma or Refractory/ Relapsed Osteosarcoma PHASE1 The goal of this clinical trial is to determine the maximum tolerated dose ...
Show More Location
Children's Healthcare of Atlanta
Learn More & Join Trial